A New Drug Used for Advanced Cancer
Clinical trial NCT03447145 · UNKNOWN
Trial details
- NCT number
- NCT03447145
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-26
- Primary completion
- 2018-12-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.